Overview

• The lab-on-a-chip platform enables rapid, non-invasive testing of cortisol and DHEA levels from saliva, providing objective data to aid in diagnosing anxiety and depression.
• The device integrates with smartphones to transmit results in minutes, enhancing accessibility for at-home and point-of-care use.
• High cortisol-to-DHEA ratios, measured by the device, are linked to chronic stress and mental health disorders, offering a more detailed physiological assessment.
• Researchers have expanded the platform to test cardiac troponin for heart attack detection and COVID-19, demonstrating its versatility across health domains.
• Clinical trials are the next step, with planned collaborations with psychiatrists to validate the platform's diagnostic accuracy and real-world utility.